Testing effectiveness (Phase 2)Not Yet RecruitingNCT04622761
What this trial is testing
Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome
Who this might be right for
Prostate Cancer
The Clatterbridge Cancer Centre NHS Foundation Trust 120